Steven Dowdy of UCSD to Speak at Nucleic Acid R & D Meeting, June 19&20, 2014, San Diego, CA
Steven F. Dowdy, Professor of Cellular and Molecular Medicine at the University of California, San Diego, School of Medicine, to give a presentation titled "Therapeutics: Bioreversible PhosphoTriester siRNN Prodrugs" at the Inaugural Nucleic Acid Research and Development Conference, June 19 & 20, 2014 in San Diego, CA.
- (1888PressRelease) April 01, 2014 - Dr. Dowdy received his Ph.D. degree from the University of California, Irvine, where he studied tumor suppression, and did his postdoctoral work with Professor Robert Weinberg at the Whitehead Institute, MIT, on tumor suppressor genes.
Prior to UCSD, Dr. Dowdy was an Assistant Professor at Washington University School of Medicine. His laboratory is focused on understanding the molecular basis of G1 cell cycle deregulation during oncogenesis, and development of novel macromolecular RNAi prodrugs called short interfering RiboNucleic Neutrals (siRNNs) that contain bioreversible phosphotriester protecting groups that are removed by intracellular enzymes to become active RNAi triggers.
For more information, please visit www.gtcbio.com/nucleicacid/agenda.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam